Tissue Diagnostics Market Insights and Trends 2022-2032

Tissue Diagnostics Market Overview

The global Tissue Diagnostics Market was valued at US$ 32.0 Bn in 2021 and is set to expand at a healthy CAGR of 12.8% during 2022-2032, with a market valuation of US$ 120.2 Bn by 2032.

“Upsurge in the cancer incidences and rising presence of various medical and biotechnology firms across the world is expected to uplift the tissue diagnostics market growth.”

A group of human cells that play an important role in executing several biological functions that are crucial for other healthy functions in the human body are referred to as tissues. Tissue diagnostics is an important field of diagnostics research. The tissue sample explains several aspects of the different biological situations.

Tissue diagnostics have played a major role in the field of cancer analysis and diagnostics. It helps researchers and scientists to identify the presence of cancer by examining the tissue samples. It is also gaining popularity in the different diagnostic fields. In the leading pharmaceutical companies, the study of different chronic diseases’ origin and treatment is carried out. Due to this Tissue Diagnostics are gaining more popularity in other diagnostics areas.

What are the Factors Responsible for the Growth of the Tissue Diagnostics Market?

The increasing incidence and prevalence of various types of cancer, such as lung cancer and breast cancer, are expected to boost the tissue diagnostics market over the forecast period.

Additionally, innovations in devices to detect the type of cancerous tissue, a spike in technical enhancements that support the improved imaging of hazardous cells, and a rise in the precision of the outcome could help the tissue diagnostics market in achieving growth throughout the forecast period. Furthermore, increased government and private organizations’ initiatives to create awareness to identify and prevent early cancer are predicted to propel market expansion in the projected years.

Moreover, improved infrastructure of diagnostics laboratories in developed countries is expected to boost the market in the near future. Owing to the growing disposable income of the populace, the spending capability of people on health has increased. Thus, people concerned about their health are highly spending money on diagnostic treatments, even for minor symptoms. This will boost market demand.

Which Region Shows Strong Growth Potential in the Tissue Diagnostics Market?

On the basis of geographies, the global tissue diagnostics market is divided into seven major regions- North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

The tissue diagnostic market in North America is expected to maintain its hold during the forecast period followed by Europe and the Asia Pacific. Owing to the factors such as high spending on research and development activities in the biotechnology and medical equipment organizations as well as the extensive use of novel technologies, the North American region is attributed to boosting the market growth in the upcoming years.

On the other hand, Asia Pacific is anticipated to show rapid growth in the projected period. The upsurge in the medical tourism business in the nations like China and India is expected to increase the demand for diagnosis and treatment in this region. Furthermore, due to the increase in cancer cases and other disorders will further propel the market growth for tissue diagnostics.

Who are the Key Market Players in the Tissue Diagnostics Market?

Some of the key players operating in the infection control market are Agilent Technologies, Danaher Corporation, F. Hoffmann-La Roche Ltd, BIOMÉRIEUX, Abbott Laboratories, Merck KGaA, General Electric Company (GE Healthcare), BioGenex, Cell Signaling Technology, Inc., and Koninklijke Philips N.V.

Key Segments Covered in the Tissue Diagnostics Market Report

By Product:

  • Instruments
  • Microscope
  • Non-contact Handheld IR Thermometer
  • Haemocytometer
  • NMR Tube
  • Others
  • Consumables
  • Reagent Kits
  • Others

By Disease:

  • Lung Cancer
  • Lymphoma
  • Pancreatic
  • Cancer
  • Breast Cancer
  • Others

By Application:

  • In Situ Hybridization
  • Hematoxylin and Eosin (H&E)
  • Immunohistochemistry (IHC)

By End User:

  • Diagnostic Laboratories
  • Hospitals
  • Contract Research Organizations
  • Research Organizations
  • Biotechnology Companies

Read More@ https://www.futuremarketinsights.com/reports/tissue-diagnostics-market

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more